Emerald Medical Applications

What Emerald Medical Applications does

Emerald Medical Applications was founded in 2010 in Petah Tiqva, Israel, and is associated with the OTCQB ticker MRLA, which source data now indicates is delisted. The company was originally positioned around a population-wide melanoma screening proposition, but no proprietary technology, AI/ML capabilities, clinical validation, regulatory clearances, or product details are disclosed in the source data. Headcount is reported at 1-10 employees and no pricing model, customer segments, or revenue mechanics are documented.

The company's only currently observable operating asset is the Derma Compare Health Engine website (dermacompare.com), which functions as a consumer-facing health information portal. The site publishes articles spanning plastic surgery recovery, blood pressure management, hair transplants, psychedelics therapy, cosmetic dentistry, dental care, infertility, skin diseases, acid reflux, CBD products, cannabis health benefits, contact lens care, anxiety, and breast cancer prevention. Content authorship is attributed to named freelancers (e.g., Maximilian Huff, Victoria Lawson), with publication dates ranging from 2018 through 2025. A Facebook page and Pinterest profile provide supplementary social distribution.

The company's capital history consists of a single disclosed $1,000,000 funding event in May 2016 from Kodiak Capital Group. No management team, board, ownership structure, partnerships, M&A activity, or subsequent capital raises are documented. The disconnect between the original melanoma-screening mission and the current generalist health content operation, combined with delisted status and minimal headcount, signals an entity that has either substantially pivoted, wound down core operations, or maintains only nominal corporate activity.

Name

Emerald Medical Applications

Legal name

Derma Compare Health Engine

Website

https://dermacompare.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Emerald Medical Applications (Derma Compare Health Engine) is an Israel-based, now privately held company that operates dermacompare.com, a consumer-facing health information portal publishing articles on diverse medical and wellness topics, with no proprietary technology or revenue model disclosed.

Ownership category

akta.pro rank

Product category

Skin Cancer Screening

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKACAA

General & Medical Dermatology

Healthcare & Life Sciences/Specialist Medical Practice/Dermatology

SECONDARYHLAKACAC

Dermatopathology

Healthcare & Life Sciences/Specialist Medical Practice/Dermatology

Keywords

• Melanoma screening software
• Dermatology screening platform
• Skin lesion analysis
• Health information portal
• Medical content publishing

Headquarters

HQ city

Petah Tiqva

HQ country

Israel

HQ region

Middle East

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Core offering

Emerald Medical Applications positions itself as the first of its kind population-wide melanoma screening offering, marketed through its consumer-facing Derma Compare Health Engine website. The active site publishes general health editorial content across dermatology, plastic surgery recovery, blood pressure, hair transplants, psychedelics, cosmetic dentistry, and related wellness topics rather than a documented screening workflow.

Product overview

The source data does not contain information about Emerald Medical Applications. The content primarily covers Derma Compare Health Engine (dermacompare.com), a health information website that publishes articles on various health topics including plastic surgery recovery, blood pressure management, hair transplants, psychedelics therapy, cosmetic dentistry, protein nutrition, dental care, infertility, skin diseases, cosmetic surgery procedures, acid reflux diet, CBD products, cannabis health benefits, cycling, table tennis, sexual health, lip augmentation, contact lens care, anxiety management, and breast cancer prevention.

Differentiator

Problem solved

Functional benefit

Products and services

• Derma Compare Health Engine
• Population-Wide Melanoma Screening

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Healthline: Healthline is a large-scale health information publisher with medically-reviewed dermatology and skin-health sections. It is the closest broad incumbent to what dermacompare.com operates as in practice.
• Verywell Health: Verywell Health publishes medically-reviewed consumer health content across dermatology and adjacent topics, and is a comparable incumbent competing for the same general health-content traffic dermacompare.com targets.
• DermAssist (Google Health): Google's DermAssist is a web-based AI dermatology triage tool that matches user photos to dermatologic conditions. It represents a major incumbent threat in the dermatology self-screening category where Emerald Medical would compete if it relaunched its screening product.
• WebMD: WebMD is a dominant consumer health information portal covering dermatology, oncology, and general wellness topics. As a broad incumbent, it competes for the same health-information/SEO audience that dermacompare.com actually serves today.

Emerging players

• SkinIO: SkinIO provides AI-based total body photography and skin lesion tracking for dermatology clinics and at-risk patients. It competes for the same melanoma/skin-cancer screening workflow that Emerald Medical claims to target, with an emerging commercial footprint.
• First Derm: First Derm offers on-demand dermatology triage via photo-based online consultations. It overlaps with Emerald Medical's stated melanoma screening goal by combining self-screening with dermatologist review in a consumer-accessible format.
• MoleMapper: MoleMapper is a research-grade iPhone app developed with OHSU that helps users track and document moles over time for melanoma monitoring. It is an emerging, partially-overlapping peer for skin self-screening functionality.

Direct peers

• MoleSafe: MoleSafe operates a melanoma surveillance and skin imaging service combining digital dermoscopy with dermatologist review. It is a directly comparable skin-lesion screening service targeting the same population-level melanoma detection use case.
• SkinVision: SkinVision offers an AI-driven smartphone app for skin lesion and melanoma risk assessment, directly comparable to the population-wide melanoma screening ambition stated by Emerald Medical Applications. Both target early melanoma/skin cancer detection via consumer-accessible technology.

Regional players

• DermNet NZ: DermNet NZ is a well-established dermatology-specific health information resource run by a New Zealand charitable trust. It represents a credible dermatology-focused information site, comparable to what Emerald Medical would need to become to differentiate.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/Derma-Compare-Health-Engine-2013644198925836
• Pinterestpinterest.com/MaximilianHuff030/derma-compare-health-engine
• Xx.com/DermaCompare
• LinkedInlinkedin.com/company/emerald-medical-applications

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emerald Medical Applications